Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study

Autor: Kuo, Kevin H M *, Layton, D Mark, Lal, Ashutosh, Al-Samkari, Hanny, Bhatia, Joy, Kosinski, Penelope A, Tong, Bo, Lynch, Megan, Uhlig, Katrin, Vichinsky, Elliott P
Zdroj: In The Lancet 13-19 August 2022 400(10351):493-501
Databáze: ScienceDirect